戻る Agenda
Session 4: Early Access Paths in Europe
Session Chair(s)
Michela Gabaldo, PHARMD, MSC
VP ATMP Global Regulatory Affairs
Evotec, Italy
Topics covered in this session include:
- How unified is the approach to early access?
- Available Early Access Schemes
- Challenges with ATMPs
- Return on Investment issues
- Chronic vs. one-time use drugs
- Outcome based agreements
- Compassionate use vs. Early Access Schemes
Speaker(s)
Sandra Petraglia, MD, PHD
AIFA - Agenzia Italiana Del Farmaco, Italy
Head of Pre Authorisation Department
Industry Perspective: Available Early Access Schemes
Oswald Bentinck
Rocket Pharmaceuticals, Inc., United States
Vice President, Global Head of Value & Access
Case Study: Early Access Paths working for ATMPs
Nicolas Koebel
EpilepsyGTx Limited, United Kingdom
Chief Executive Officer of EpilepsyGTx Limited